This inventor holds 1 USPTO granted patent. Top assignee: Biomerieux, Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Innovations of François Penin in Hepatitis C Research
Introduction
François Penin is a notable inventor based in Décines, France, recognized for his significant contributions to the field of medical research, particularly in the realm of hepatitis C virus (HCV) detection and treatment. With one patented invention to his name, he exemplifies the intersection of innovation and healthcare.
Latest Patents
François Penin holds a patent for an invention titled "Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection." This groundbreaking invention concerns a structural peptide identified by antibodies that target a 2-45 amino acid sequence of the N-terminal end of the Core or nucleocapsid (p21) protein of HCV. The invention is distinguished by its tertiary structure, comprising two peptide fragments with α-helix configurations and a third peptide bond linking them in a unique spatial arrangement. This peptide serves multiple functions, including the detection of antibodies directed against the p21 protein of HCV and the development of diagnostic, prophylactic, or therapeutic compositions for combating HCV infections.
Career Highlights
François Penin is currently affiliated with bioMérieux, Inc., a global leader in the field of in vitro diagnostics. His work within this prestigious organization underscores his commitment to advancing medical science and improving health outcomes through innovative research.
Collaborations
Throughout his career, François has collaborated with esteemed colleagues such as Michel C. Jolivet and Pascal T. Dalbon. These partnerships have further enriched his research endeavors and contributed to the broader scientific community's understanding of hepatitis C.
Conclusion
François Penin's innovative work in hepatitis C research exemplifies the critical role inventors play in addressing global health challenges. Through his pioneering patent and collaborations, he continues to contribute to the advancement of medical diagnostics and treatment strategies. His research stands as a valuable asset in the ongoing fight against HCV, showcasing the power of innovation in health science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile